Cargando…
Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study
Bullous pemphigoid is an autoimmune subepidermal blistering skin disease immunologically defined by autoantibodies directed against basement membrane zone antigens, the main of which is BP180. Laboratory tests are essential for diagnosis and include direct immunofluorescence and serologic assessment...
Autores principales: | Sernicola, Alvise, Russo, Irene, Saponeri, Andrea, Alaibac, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408141/ https://www.ncbi.nlm.nih.gov/pubmed/30762788 http://dx.doi.org/10.1097/MD.0000000000014514 |
Ejemplares similares
-
Biochip Technology for the Serological Diagnosis of Bullous Pemphigoid
por: Zarian, Haik, et al.
Publicado: (2012) -
Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid
por: Nagarajan, Harish, et al.
Publicado: (2023) -
Evaluation of the Role of BIOCHIP Mosaic Based Indirect Immunofluorescence and ELISA BP 180 and BP 230 Autoantibodies in the Diagnosis of Bullous Pemphigoid Patients
por: Nithya, VPS, et al.
Publicado: (2022) -
Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients
por: Gasparini, Giulia, et al.
Publicado: (2023) -
Association of Autoantibodies to BP180 with Disease Activity in Greek Patients with Bullous Pemphigoid
por: Patsatsi, Aikaterini, et al.
Publicado: (2012)